Latest Biomarkers Stories
Addition of Protein Biomarkers, Including Key Immune Targets PD-L1 and PD1, Further Augments Tests Ability to Personalize Cancer Therapy PHOENIX and ANN ARBOR, Mich., Feb.
Ongoing research aims to develop technologies that diagnose cancer at the cellular level before the disease manifests, finds Frost & Sullivan LONDON, Feb.
SAN DIEGO, Jan.
SAN DIEGO and MARCY L'ETOILE, France, Jan.
Lifescienceindustryresearch.com adds "Global Cancer Biomarkers Market 2015-2019" a new industry research report in its store.
After 15 years of research and development by Ancon Medical on revolutionary disease screening technology, the Minnesota-based company has developed a cutting-edge medical device that can detect
Cambridge Biomedical Inc announces collaboration with XenTech SAS based in Evry, France to jointly market CRO services to the biotech and pharmaceutical market in the USA and Europe.
Research Presented at 2015 Gastrointestinal Cancers Symposium Highlights Clinical Utility of Caris Molecular Intelligence IRVING, Texas, Jan.
PETACH TIKVA, Israel, Jan. 6, 2015 /PRNewswire/ -- Can-Fite BioPharma Ltd.
- The abrogation of a law by a higher authority; annulment.